Kidswell Bio Corporation (TYO:4584)

Kidswell Bio Statistics

Total Valuation

Kidswell Bio has a market cap or net worth of JPY 12.15 billion. The enterprise value is 11.75 billion.

Market Cap	12.15B
Enterprise Value	11.75B

Important Dates

The next estimated earnings date is Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Kidswell Bio has 49.60 million shares outstanding. The number of shares has increased by 46.93% in one year.

Current Share Class	49.60M
Shares Outstanding	49.60M
Shares Change (YoY)	+46.93%
Shares Change (QoQ)	+1.32%
Owned by Insiders (%)	5.56%
Owned by Institutions (%)	-7.61%
Float	34.45M

Valuation Ratios

The trailing PE ratio is 39.56 and the forward PE ratio is 16.55.

PE Ratio	39.56
Forward PE	16.55
PS Ratio	1.84
PB Ratio	5.56
P/TBV Ratio	5.56
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	41.95
EV / Sales	1.78
EV / EBITDA	n/a
EV / EBIT	23.17
EV / FCF	-51.29

Financial Position

The company has a current ratio of 1.80, with a Debt / Equity ratio of 0.52.

Current Ratio	1.80
Quick Ratio	1.05
Debt / Equity	0.52
Debt / EBITDA	n/a
Debt / FCF	-4.95
Interest Coverage	13.70

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	28.00%
Return on Capital Employed (ROCE)	18.26%
Weighted Average Cost of Capital (WACC)	10.19%
Revenue Per Employee	178.62M
Profits Per Employee	7.57M
Employee Count	37
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Kidswell Bio has paid 120.00 million in taxes.

Income Tax	120.00M
Effective Tax Rate	30.00%

Stock Price Statistics

The stock price has increased by +128.97% in the last 52 weeks. The beta is 1.21, so Kidswell Bio's price volatility has been higher than the market average.

Beta (5Y)	1.21
52-Week Price Change	+128.97%
50-Day Moving Average	231.54
200-Day Moving Average	239.65
Relative Strength Index (RSI)	49.83
Average Volume (20 Days)	2,711,780

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Kidswell Bio had revenue of JPY 6.61 billion and earned 280.00 million in profits. Earnings per share was 6.19.

Revenue	6.61B
Gross Profit	1.94B
Operating Income	507.00M
Pretax Income	400.00M
Net Income	280.00M
EBITDA	n/a
EBIT	507.00M
Earnings Per Share (EPS)	6.19

Balance Sheet

The company has 1.54 billion in cash and 1.13 billion in debt, with a net cash position of 407.00 million or 8.20 per share.

Cash & Cash Equivalents	1.54B
Total Debt	1.13B
Net Cash	407.00M
Net Cash Per Share	8.20
Equity (Book Value)	2.19B
Book Value Per Share	44.08
Working Capital	2.43B

Cash Flow

In the last 12 months, operating cash flow was -223.00 million and capital expenditures -6.00 million, giving a free cash flow of -229.00 million.

Operating Cash Flow	-223.00M
Capital Expenditures	-6.00M
Free Cash Flow	-229.00M
FCF Per Share	-4.62

Margins

Gross margin is 29.28%, with operating and profit margins of 7.67% and 4.24%.

Gross Margin	29.28%
Operating Margin	7.67%
Pretax Margin	6.05%
Profit Margin	4.24%
EBITDA Margin	n/a
EBIT Margin	7.67%
FCF Margin	n/a

Dividends & Yields

Kidswell Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-46.93%
Shareholder Yield	-46.93%
Earnings Yield	2.30%
FCF Yield	-1.88%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on June 27, 2018. It was a forward split with a ratio of 2.

Last Split Date	Jun 27, 2018
Split Type	Forward
Split Ratio	2

Scores

Kidswell Bio has an Altman Z-Score of 3.02 and a Piotroski F-Score of 2.

Altman Z-Score	3.02
Piotroski F-Score	2